Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized clinical study aimed to compare the clinical and radiographic outcomes of TheraCal PT and Biodentine in pulpotomy treatment of primary teeth and to evaluate the influence of low-level laser therapy (LLLT) on treatment outcomes in pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedDecember 11, 2025
November 1, 2025
2.5 years
November 18, 2025
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical and Radiographic Success Rate of Pulpotomy Treatments in Primary Molars
Number of teeth with clinical success defined as absence of spontaneous pain, swelling, sinus tract, pathological mobility, or tenderness to percussion, and number of teeth with radiographic success defined as absence of internal or external root resorption and absence of furcal or periapical radiolucency. Results will be reported as number and percentage of successful teeth.
12 months after treatment
Secondary Outcomes (2)
Interim Clinical and Radiographic Success Rates
3 and 6 months after treatment
Effect of Low-Level Laser Therapy (LLLT) on Pulpotomy Success
12 months after treatment
Study Arms (4)
Biodentine
ACTIVE COMPARATORPrimary molars treated with pulpotomy using Biodentine without low-level laser therapy (LLLT). After coronal pulp removal, Biodentine (Septodont, France) was placed over the remaining pulp tissue. No laser application was performed.
LLLT + Biodentine
EXPERIMENTALPrimary molars treated with Biodentine pulpotomy combined with low-level laser therapy. After pulpotomy, diode laser (940 nm, 10 s, non-contact mode) was applied over the pulp chamber floor, followed by placement of Biodentine (Septodont, France).
TheraCal PT
EXPERIMENTALPrimary molars treated with pulpotomy using TheraCal PT without low-level laser therapy. After coronal pulp removal, TheraCal PT (Bisco Inc., USA) was applied directly onto the pulp tissue. No laser application was performed.
LLLT + TheraCal PT
EXPERIMENTALPrimary molars treated with TheraCal PT pulpotomy combined with low-level laser therapy. Following pulpotomy, a 940 nm diode laser (Biolase, USA) was applied for 10 seconds in non-contact mode, followed by application of TheraCal PT (Bisco Inc., USA).
Interventions
After coronal pulp removal, Biodentine (Septodont, France) was placed over the remaining pulp tissue. No laser application was performed.
After pulpotomy, diode laser (940 nm, 10 s, non-contact mode) was applied over the pulp chamber floor, followed by placement of Biodentine (Septodont, France).
After coronal pulp removal, TheraCal PT (Bisco Inc., USA) was applied directly onto the pulp tissue. No laser application was performed.
Following pulpotomy, a 940 nm diode laser (Biolase, USA) was applied for 10 seconds in non-contact mode, followed by application of TheraCal PT (Bisco Inc., USA).
Eligibility Criteria
You may qualify if:
- Healthy children aged between 6 and 9 years. Primary molars with carious exposures requiring pulpotomy treatment. Teeth with vital pulp confirmed by the absence of spontaneous pain and the presence of normal bleeding after coronal pulp removal.
- Teeth with restorable crowns suitable for stainless steel crown restoration. Cooperative patients who can attend all follow-up appointments.
You may not qualify if:
- Teeth with signs of irreversible pulpitis or necrosis (e.g., spontaneous or nocturnal pain).
- Teeth with internal or external root resorption, furcal or periapical radiolucency.
- Non-restorable teeth or those with excessive loss of crown structure. Patients with systemic diseases or on long-term medication that could affect healing.
- Uncooperative children or those lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NECIBE DAMLA ŞAHINlead
- Tokat Gaziosmanpasa Universitycollaborator
Study Sites (1)
Tokat Gaziosmanpasa University Faculty of Dentistry
Tokat Province, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Necibe Damla ŞAHİN, DDS, PhD
Tokat Gaziosmanpaşa University, Faculty of Dentistry, Department of Pediatric Dentistry, Tokat, Turkey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to the treatment groups during clinical and radiographic evaluations. Participants and operators were not blinded due to the nature of the interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 18, 2025
First Posted
December 11, 2025
Study Start
January 5, 2023
Primary Completion
July 5, 2025
Study Completion
October 15, 2025
Last Updated
December 11, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because this study involved pediatric participants and the data contain potentially identifiable information. Only summary data will be available in the published article.